Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

In Silico Study of Rett Syndrome Treatment-Related Genes, MECP2, CDKL5, and FOXG1, by Evolutionary Classification and Disordered Region Assessment.

Fahmi M, Yasui G, Seki K, Katayama S, Kaneko-Kawano T, Inazu T, Kubota Y, Ito M.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5593. doi: 10.3390/ijms20225593.

2.

Yokukansan, a Kampo medicine, enhances the level of neuronal lineage markers in differentiated P19 embryonic carcinoma cells.

Fukui M, Katayama S, Ikeya Y, Inazu T.

Heliyon. 2019 Oct 16;5(10):e02662. doi: 10.1016/j.heliyon.2019.e02662. eCollection 2019 Oct.

3.

Straightforward and rapid method for detection of cyclin-dependent kinase-like 5 activity.

Katayama S, Inazu T.

Anal Biochem. 2019 Feb 1;566:58-61. doi: 10.1016/j.ab.2018.11.013. Epub 2018 Nov 14.

PMID:
30447183
4.

HDAC8 regulates neural differentiation through embryoid body formation in P19 cells.

Katayama S, Morii A, Makanga JO, Suzuki T, Miyata N, Inazu T.

Biochem Biophys Res Commun. 2018 Mar 25;498(1):45-51. doi: 10.1016/j.bbrc.2018.02.195. Epub 2018 Feb 28.

PMID:
29499194
5.

Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study.

Kawahara T, Suzuki G, Inazu T, Mizuno S, Kasagi F, Okada Y, Tanaka Y.

BMJ Open. 2016 Jul 7;6(7):e011183. doi: 10.1136/bmjopen-2016-011183.

6.

A novel CDKL5 mutation in a Japanese patient with atypical Rett syndrome.

Christianto A, Katayama S, Kameshita I, Inazu T.

Clin Chim Acta. 2016 Aug 1;459:132-136. doi: 10.1016/j.cca.2016.06.003. Epub 2016 Jun 2.

PMID:
27265524
7.

A Novel PHEX Mutation in Japanese Patients with X-Linked Hypophosphatemic Rickets.

Kawahara T, Watanabe H, Omae R, Yamamoto T, Inazu T.

Case Rep Genet. 2015;2015:301264. doi: 10.1155/2015/301264. Epub 2015 Mar 15.

8.

Incidence of type 2 diabetes in pre-diabetic Japanese individuals categorized by HbA1c levels: a historical cohort study.

Kawahara T, Imawatari R, Kawahara C, Inazu T, Suzuki G.

PLoS One. 2015 Apr 8;10(4):e0122698. doi: 10.1371/journal.pone.0122698. eCollection 2015.

9.

Generation of rat induced pluripotent stem cells using a plasmid vector and possible application of a keratan sulfate glycan recognizing antibody in discriminating teratoma formation phenotypes.

Makanga JO, Kobayashi M, Ikeda H, Christianto A, Toyoda H, Yamada M, Kawasaki T, Inazu T.

Biol Pharm Bull. 2015;38(1):127-33. doi: 10.1248/bpb.b14-00697. Erratum in: Biol Pharm Bull. 2015;38(4):634.

10.

Allele-specific real-time polymerase chain reaction as a tool for urate transporter 1 mutation detection.

Makanga JO, Christianto A, Inazu T.

Methods Mol Biol. 2015;1275:117-25. doi: 10.1007/978-1-4939-2365-6_8.

PMID:
25697655
11.

Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.

Christianto A, Watanabe H, Nakajima T, Inazu T.

Clin Chim Acta. 2013 Aug 23;423:66-8. doi: 10.1016/j.cca.2013.04.022. Epub 2013 Apr 30.

PMID:
23726270
12.

Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.

Kawahara T, Nishikawa M, Kawahara C, Inazu T, Sakai K, Suzuki G.

Circulation. 2013 Jun 11;127(23):2327-35. doi: 10.1161/CIRCULATIONAHA.113.001534. Epub 2013 May 8.

PMID:
23658438
13.

Simple and rapid detection method for the mutations in SLC22A12 that cause hypouricemia by allele-specific real-time polymerase chain reaction.

Takagi S, Omae R, Makanga JO, Kawahara T, Inazu T.

Clin Chim Acta. 2013 Jan 16;415:330-3. doi: 10.1016/j.cca.2012.10.046. Epub 2012 Nov 10.

PMID:
23148994
14.

Tandem configurations of variably duplicated segments of 22q11.2 confirmed by fiber-FISH analysis.

Shimojima K, Okamoto N, Inazu T, Yamamoto T.

J Hum Genet. 2011 Nov;56(11):810-2. doi: 10.1038/jhg.2011.100. Epub 2011 Aug 25.

PMID:
21866110
15.

Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging.

Kawahara T, Nishikawa M, Furusawa T, Inazu T, Suzuki G.

J Atheroscler Thromb. 2011;18(5):384-95. Epub 2011 Jan 26.

16.

Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu Diabetes Prevention Trial.

Kawahara T, Takahashi K, Inazu T, Arao T, Kawahara C, Tabata T, Moriyama H, Okada Y, Morita E, Tanaka Y.

Diabetes Care. 2008 Oct;31(10):1949-54. doi: 10.2337/dc07-2272. Epub 2008 Jun 30.

17.

Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.

Kitaura Y, Jang IK, Wang Y, Han YC, Inazu T, Cadera EJ, Schlissel M, Hardy RR, Gu H.

Immunity. 2007 May;26(5):567-78. Epub 2007 May 10.

18.

Rapid detection of R90H mutations in the human urate transporter 1 gene.

Inazu T, Kawahara T, Ishikawa I.

Ann Clin Biochem. 2007 Mar;44(Pt 2):189-91.

PMID:
17362586
19.

Molecular cloning, expression and chromosomal localization of mouse MM-1.

Inazu T, Myint Z, Kuroiwa A, Matsuda Y, Noguchi T.

Mol Biol Rep. 2005 Dec;32(4):273-9.

PMID:
16328889
20.

Cloning, expression and chromosomal assignment of human pleckstrin 2.

Inazu T, Kuroiwa A, Matsuda Y, Miyamoto K.

Mol Biol Rep. 2005 Mar;32(1):35-40.

PMID:
15865208

Supplemental Content

Loading ...
Support Center